FDA Inspection 969376 — Ascensia Diabetes Cares US Inc.

Ascensia Diabetes Cares US Inc. — FEI 3010700165

The FDA completed an inspection of Ascensia Diabetes Cares US Inc. on Mar 2, 2016 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 2, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.